HCA Healthcare, Inc.

HCA · NYSE · USD

Can HCA's cost-savings program and continued volume growth offset the loss of exchange coverage and smaller Medicaid supplemental payments?

Last 4 earnings calls · through Q2 FY2026

Bull case

  • Steady demand for care

    The bull case is that demand for hospital and outpatient care keeps growing in HCA's markets, so volume growth continues despite payer headwinds.

  • Cost savings program

    Management has committed to a quantified cost-savings program and expects it to absorb much of the insurance-exchange revenue loss this year.

  • Network and capacity investment

    Capital spending on beds, emergency departments and outpatient sites is meant to let HCA take share as its markets grow and hospitals run near capacity.

  • Reimbursement program approvals

    State supplemental payment approvals, including Florida's, have repeatedly added revenue that was not in the plan, supporting earnings while core growth moderates.

Bear case

  • Exchange patients becoming uninsured

    The bear case is that patients who lost subsidized exchange coverage arrive uninsured rather than enrolling elsewhere, permanently lowering what HCA collects per patient.

  • Elective procedure volume

    Elective surgeries are falling faster than last year, which management links partly to lost exchange coverage and patient affordability rather than to competition.

  • Supplemental payment variability

    Medicaid supplemental payments are volatile, approved state by state, and management expects the second half of the year to bring a net decline from them.

  • Cash flow and leverage

    Cash generation has weakened while buybacks and dividends exceed free cash flow, and net debt has risen, leaving less room if earnings disappoint.

Bull and bear points

Growth & Execution

In short: Volume growth should continue from added capacity, while elective procedures decline.

Bull · 2

  • Nineteen straight quarters of volume growth

    Management says demand in its markets has grown every quarter for nearly five years, which underpins its long-term assumption of 2% to 3% volume growth.

    Q4 FY2025 call

  • Inpatient beds and outpatient sites

    Management has approved about $7 billion of projects over three years that add hospital beds, emergency room capacity and outpatient facilities, supporting volume growth into 2027 and 2028.

    Q2 FY2026 call
Bear · 2

  • Guidance reaffirmed in April, cut in July

    Management reaffirmed the full-year range in April, then cut revenue and earnings in July and said growth would return only to its long-term 4% to 6% rate.

    Tone shiftQ1 FY2026 → Q2 FY2026

  • Elective surgeries falling faster

    Inpatient elective cases are down about 6% this year after a 2% decline last year, and management attributes much of the drop to patients who lost exchange coverage.

    Q2 FY2026 call

Profitability & Financial Strength

In short: Cost discipline has supported margins, while cash generation weakened and buybacks exceed free cash flow.

Bull · 2

  • Resiliency savings moved from target to number

    Last fall management promised detail with 2026 guidance rather than a figure; it then put $400 million of savings in the 2026 plan and calls the program multiyear.

    Tone shiftQ3 FY2025 → Q4 FY2025

  • Cost per admission held flat

    Same-facility cost per equivalent admission was essentially flat versus the prior year in the second quarter, which management credits to the resiliency program despite the payer mix shift.

    Q2 FY2026 call
Bear · 2

  • Supplemental payment benefit falls in second half

    The second half of 2026 carries a $100 million to $300 million decline in supplemental payment net benefit as 2025 approvals and retro payments lap.

    Q2 FY2026 call

  • Buybacks exceed free cash flow

    HCA returned $9.4 billion to shareholders over the last year, 156% of free cash flow, so buybacks and dividends are funded partly beyond what operations generate.

    Filed financials

Market Position

In short: Scale and service diversity help, but revenue is concentrated in Florida and Texas and government programs.

Bull · 2

  • No division or service line dominates results

    Management says no single geographic division generates more than 10% of company profits and no service line more than 15% of revenue, which limits single-market risk.

    Q4 FY2025 call

  • Market growth supports share gains

    Management says population trends in its Florida, Texas and mountain-state markets match the pandemic-era migration, and it judges competitive position stable or improving.

    Q2 FY2026 call
Bear · 2

  • Medicaid work requirements target expansion states

    Proposed federal Medicaid work requirements would hit expansion states harder than others, and HCA says it is preparing coverage-support teams while legal challenges proceed.

    Q2 FY2026 call

  • Revenue concentrated in Florida and Texas

    The annual report says 102 of 190 hospitals and 51% of revenue sit in Florida and Texas, so state Medicaid policy, hurricanes and local competition hit a large share at once.

    10-K, filed 2026-02-10